Abstract
Stem cell transplantation (SCT) has the potential to transform the lives of children with a wide variety of genetic diseases, ranging from inherent defects of hemopoietic cell production or function through to metabolic diseases mostly affecting solid organs. For these children life expectancy or quality of life would otherwise be very poor.1 It ranks as one of the most remarkable therapeutic advances of the past 40 years. Despite rapid technological improvements, however, there are still many short term risks and potential long term toxicities. Consequently, the rapid emergence of alternative therapies (including new drugs, enzyme and gene therapies), necessitate constant re-evaluation of the risk/benefit ratio for each disease and hence the appropriateness of SCT. This review describes the major aspects of the transplant process, indications for transplantation, outcome statistics, and areas where alternative therapies are becoming available. SCT remains a highly experimental therapy. Due to the relatively short history of the discipline no data exists on truly long term follow up. This is important as some organs benefit relatively poorly or problems may emerge which were never apparent as part of the untreated disease. The speed of technological change makes randomised trials on these diseases, which are individually quite rare, almost impossible to perform.
Similar content being viewed by others
References
Steward CG. Stem cell transplantation for non-malignant disorders. Baillieres Best Pract Res Clin Haematol 2000; 13: 343–363.
Wollert KC, Drexler H. Clinical applications of stem cells for the heart. Circ Res 2005; 96: 151–163.
Lagasse E, Connors H, Al-Dhalimy M et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000; 6: 1229–1234.
Xu Leyan, Yan Jun, Chen David et al. Human Neural Stem Cell Grafts Ameliorate Motor Neuron Disease in SOD-1 Transgenic Rats. Transplantation 2006; 82: 865–875.
de Kleer I, Vastert B, Klein M et al. Autologous stem cell transplantation for autoimmunity induces immunologic selftolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network. Blood 2006 15; 107: 1696–702.
Wulffraat NM, de Kleer IM, Prakken B et al. Refractory juvenile idiopathic arthritis: using autologous stem cell transplantation as a treatment strategy. Expert Rev Mol Med 2006; 8: 1–11
Sampaolesi M, Blot S, D’Antona G. Mesoangioblast et al. Stem cells ameliorate muscle function in dystrophic dogs. Nature 2006; 444: 574–579.
Ravindranath Y, Chang M, Steuber CP et al. Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000. Leukemia 2005; 19: 2101–2116.
Thomas ED. Bone marrow transplantation: a review. Semin Hematol 1999; 36: 95–103.
Verlinsky Y, Rechitsky S, Schoolcraft W, Strom C, Kuliev A. Preimplantation diagnosis for Fanconi anemia combined with HLA matching. JAMA 2001; 285: 3130–3133.
Flake AW, Zanjani, eds. In utero hematopoietic stem cell transplantation: ontogenic opportunities and biologic barriers. Blood 1999; 94: 2179–2191.
MacKintosh FR, Adlish J, Hall SW et al. Suppression of normal human hematopoiesis by cytomegalovirus in vitro. Exp Hematol 1993; 21: 243.
Young NS. Acquired aplastic anemia. Ann Intern Med 2002; 136: 534–546.
Lum LG. The kinetics of immune reconstitution after human marrow transplantation. Blood 1987; 69: 369–380.
Storek J, Ferrara S, Ku N, Giorgi JV, Champlin RE, Saxon A. B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny? Bone Marrow Transplant 1993; 12: 387–398.
Lucarelli G, Andreani M, Angelucci E. The cure of thalassemia by bone marrow transplantation. Blood Rev 2002; 16: 81–85.
Sevilla J, Fernandez-Plaza S, Diaz MA et al. Hematopoietic transplantation for bone marrow failure syndromes and thalassemia. Bone Marrow Transplant 2005; 35: S17–S21.
Vassiliou G, Amrolia P, Roberts IA. Allogeneic transplantation for haemoglobinopathies. Best Pract Res Clin Haematol 2001; 14: 807–822.
Antoine C, Muller S, Cant A et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet 2003; 361: 553–560.
Buckley RH, Schiff SE, Schiff RI et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 1999; 340: 508–5016.
Buckley RH. Treatment options for genetically determined immunodeficiency. Lancet 2003; 361: 541–542.
Ozsahin H, Le Deist F, Benkerrou M et al. Bone marrow transplantation in 26 patients with Wiskott-Aldrich syndrome from a single center. J Pediatr 1996; 129: 238–244.
Rosenberg PS, Socie G, Alter BP et al. Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood 2005; 105: 67–73.
Vellodi A. Lysosomal storage disorders. Br J Haematol 2005; 128: 413–431.
Foot ABM, Potter MN, Donaldson C et al. Immune reconstitution after BMT in children. Bone Marrow Transplant 1993; 11: 7–13.
Kook H, Goldman F, Padley D et al. Reconstruction of the immune system after unrelated or partially matched T-celldepleted bone marrow transplantation in children: immunophenotypic analysis and factors affecting the speed of recovery. Blood 1996; 88: 1089–1097.
Kook H, Goldman F, Giller R et al. Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: functional analyses of lymphocytes and correlation with immunophenotypic recovery following transplantation. Clin Diagn Lab Immunol 1997; 4: 96–103.
Hochberg EP, Chillemi AC, Wu CJ et al. Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults. Blood 2001; 98: 1116–1121.
Hayashi S, Peranteau WH, Shaaban AF, Flake AW. Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusion. Blood 2002; 100: 804–812.
Turkiewicz D et al. Monitoring of hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation (alloSCT) by dual-color FISH analysis of X and Y chromosomes. Leuk Res 2003; 27: 993–998.
Robert Lowsky, MD et al. Protective Conditioning for Acute Graft-versus-Host Disease NEJM 2005; 353; 1321–1331.
Navneet S. Majhail et al. Double umbilical cord blood transplantation. Current Opinion in Immunology 2006; 18: 571–575.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sharma, V.K., Singh, U.K., Prasad, R. et al. Stem Cell Through Present and Future. Indian J Pediatr 76, 51–56 (2009). https://doi.org/10.1007/s12098-009-0029-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-009-0029-x